Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Assets Average (2016 - 2025)

Historic Assets Average for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Q3 2025 value amounting to $369.5 million.

  • Ironwood Pharmaceuticals' Assets Average fell 587.55% to $369.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.5 million, marking a year-over-year decrease of 587.55%. This contributed to the annual value of $411.0 million for FY2024, which is 4769.76% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Assets Average stood at $369.5 million for Q3 2025, which was down 587.55% from $335.1 million recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' Assets Average ranged from a high of $1.1 billion in Q1 2023 and a low of $335.1 million during Q2 2025
  • For the 5-year period, Ironwood Pharmaceuticals' Assets Average averaged around $710.0 million, with its median value being $579.3 million (2021).
  • Its Assets Average has fluctuated over the past 5 years, first surged by 12295.9% in 2021, then tumbled by 5966.43% in 2024.
  • Quarter analysis of 5 years shows Ironwood Pharmaceuticals' Assets Average stood at $1.1 billion in 2021, then decreased by 2.97% to $1.1 billion in 2022, then plummeted by 53.52% to $497.6 million in 2023, then dropped by 25.6% to $370.2 million in 2024, then fell by 0.19% to $369.5 million in 2025.
  • Its Assets Average was $369.5 million in Q3 2025, compared to $335.1 million in Q2 2025 and $339.1 million in Q1 2025.